Skip to main content
Assistant Professor  |  Clinician Investigator

Helena Kim

Adult Psychiatry and Health Systems

MD, PhD, FRCPC

Location
Centre for Addiction & Mental Health
Address
100 Stokes Street, Toronto, Ontario Canada M6J 1H4
Research Interests
Development of clinical decision support tools and treatment algorithms using machine learning and biostatistical integration of clinical and biomarker data in complex mood disorders; precision psychiatry; prediction modeling
Appointment Status
Primary

Dr. Helena Kim is an Assistant Professor in the Department of Psychiatry at the University of Toronto and SCOPE lead at the Centre for Addiction and Mental Health (CAMH). She is also a psychiatrist at the University of Toronto, Student Health & Wellness. Dr. Kim completed her CIHR-funded clinical research fellowship in complex mood disorders where she developed clinical decision-support tools by analyzing datasets from randomized controlled trials (RCT). She also holds a PhD in Pharmacology and Toxicology where she examined downstream targets of mitochondrial dysfunction in bipolar disorder, with postdoctoral training in predictive modeling focusing on genetic markers of treatment response in depression. Her work to date produced decision-support tools to guide pharmacotherapy decisions in major depressive disorder, treatment-resistant depression, late-life depression, and perinatal depression. She also led a PSI Foundation-funded study examining racial disparities in antidepressant treatment following a psychiatric consultation, identifying structural inequities and opportunities for improvement through standardized care pathways and targeted quality improvement interventions. 

Dr. Kim develops clinical decision support tools and treatment algorithms using biostatistics and machine learning applied to randomized controlled trial, electronic medical record, and human molecular and imaging datasets for the treatment of complex mood disorders. The ultimate goal of her research is to translate these data-driven insights into earlier treatment optimization, reduced exposure to ineffective treatments, and more personalized interventions for patients with complex mood disorders across diverse populations. 

Recent Publications

https://pubmed.ncbi.nlm.nih.gov/40534411/ 

https://journals.lww.com/psychopharmacology/abstract/9900/toward_precision_psychiatry__using_clinical_and.555.aspx 

https://pubmed.ncbi.nlm.nih.gov/38503927/ 

Awards and Honours

2026 American College of Neuropsychopharmacology (ACNP) Travel Award 

2025 American Society of Clinical Psychopharmacology (ASCP) New Investigator Award 

2024 Association of Chairs of Psychiatry in Canada Annual Research Award  

2023 American Association of Geriatric Psychiatry (AAGP) Scholar Award